Аналитика NYSE на 20 ноября

Спайдер незначительно повышается перед открытием торгов на NYSE.  

• Европейские индексы на отрицательной  территории.  

SPY (внутридневной график) боковое движение  на премаркете    премаркете. Поддержка 178.80, сопротивление 179.80           
Премаркет NYSE/NASDAQ:
Повышаются на премаркете:

• In reaction to strong earnings/guidance: STV +9.2%, LZB +8.5% (also increased its quarterly dividend by 50% to $0.06 per share), JCP +5.4%, DE +3.7%, ADT +0.9%, (also enters into accelerated share repurchase agreement to repurchase ~400 mln of common stock).
• M&A news: TEVA +1.6% (Bloomberg discusses merger possibility between Teva and Mylan or VRX, according to reports; upgraded to Positive from Neutral at Susquehanna).
• Select oil/gas related names showing strength: SD +4.5%, RDS.A +0.8%, BP +0.7%.
• Select solar names showing strength: RSOL +10.8%, SPWR +4.3%, JKS +3.4%, TSL +3%, YGE +2.2%, SOL +1.6%.
• Other news: IPCI +21.2% (continued strength), HNR +19.5% (announces revised $400 mln proposal from Pluspetrol for co's interest in Venezuela; termination of negotiations with Vitol), UNIS +17.9% (attributed to reports of deal with Hikma), BMRN +4.9% (confirms FDA Advisory Commitee recommends approval for Vimizim for the treatment of patients with Morquio A syndrome), MDR +4.4% (ticking higher, subsidiaries was awarded project for a customer in the Arabian Gulf. The value is approximately US$ 200 million and will be included in McDermott's fourth quarter 2013 backlog), VEEV +4.3% ( following positive Mad Money mention), OMER +4.1% (announces FDA acceptance of Omidria as proprietary name for OMS302), OTIV +3.3% (Silk & Sons disclosed stake), YHOO +3.1% (increases share buyback authorization by $5 bln), NQ +2.9% (following conference yesterday), NOK +2.6% and ALU +1.3% (still checking), RYAAY +2.3% /  ZNH +1.1%  (still checking), ARO +2% ( Hirzel Capital disclosed stake), BSX +1.2% (receives FDA clearance and CE Mark approval for Direxion Torqueable Microcatheter), SSYS +1.2% (continued momentum), HLF +0.8% (William P. Stiritz, Chairman of Post Foods (POST), disclosed 6.38% active stake in 13D filing; plans to interact with Company management), CRM +0.7% ( following positive Mad Money mention), CAT +0.6% (following DE results), ZNGA +0.5% (picked up in afternoon trade on reports that the co received favorable patent verdict in Texas case), AMGN +0.5% (announces evolocumab (AMG 145) results from first 52-week study of PCSK9 inhibitor to reduce LDL cholesterol; Amgen tgt to $142 from $138 at Deutsche Bank), FNF +0.4% (Dan Loeb's Third Point Capital reported new stakes (as of 9/30) in FNF (2.1 mln shares) and NLSN (1.0 mln) in an amended 13F filing out last night after the close).
• Analyst comments: COG +2.1% (upgraded to Outperform from Market Perform at Bernstein ), PCLN +1.8% (added to Conviction Buy list at Goldman), BBY +1.6% (upgraded to Buy from Neutral at Citigroup), PSO +1.4% (ticking higher, upgraded to Buy from Neutral at BofA), GMCR +1.3% ( initiated with a Buy at Buckingham Research).

Снижаютсянапремаркете:

• In reaction to disappointing earnings/guidance: CHLN -15.8%, QUNR -5.8%, GFI -4.2%, LOW -3.8%, MODN -3% .
• Select metals/mining stocks trading lower: IAG -2.3%, GG -1.2%, AG -1.1%, ABX -1%, GLD -0.8%, EGO -0.8%, HL -0.8%.
• Other news: AEZS -8.2% (announces proposed public offering of common shares and warrants), CRNT -6.9% (announces proposed public offering of common stock, size not disclosed), LOV -6.5% (announced that Great Hill Partners, LLC and its affiliates, as selling stockholders, intend to sell shares of common stock of Spark Networks), SSW -5.7% ( plans to offer 3.5 mln Class A common shares in a registered public offering ), ICLD -5.3% (modestly pulling back), FU -4.8% (lower despite reiterating denial of allegations), GOOD -4% (plans to sell shares of its common stock in an underwritten public offering), NHI -1.8% (announces offering of 4.5 million shares of common stock; to acquire 25 independent living facilities), TEF -1.3% (still checking), BUD -1.1% (still checking), GPK -0.9% (announces commencement of secondary common stock offering of ~47.87 mln shares by selling stockholders; announces $200 mln stock repurchase), CLVS -0.6% (acquires Ethical Oncology Science to gain rights to lucitanib, a unique dual-selective Phase 2 FGFR/VEGFR inhibitor, files for 3,713,731 share common stock offering by selling shareholders).
• Analyst comments: TWTR -2% (downgraded to Hold from Buy at Cantor), CHRW -1.6% (downgraded to Hold from Buy at Deutsche Bank), WDAY -1.4% (downgraded to Market Perform from Outperform at Cowen), TSLA -1.3% (Hearing tgt cut to $120 from $141 at Barclays), PDCO -0.7% (Patterson Companies downgraded to Neutral from Buy at UBS), BA -0.7% (downgraded to Perform from Outperform at Oppenheimer), MOS -0.6% ( downgraded to Hold from Buy at BGC Partners), POT -0.6% (downgraded to Hold from Buy at BGC Partners)

 
Интересные новостные акции NYSEи NASDAQ:
DE– шорт ниже 85.00
LZB– лонг выше максимума премаркета
LOW– лонг выше максимума премаркета
Shark Traders предлагает пройти всем своим трейдерам абсолютно бесплатное обучение трейдингу на NYSE. От вас потребуется только торговый счет и желание развиваться. Вы еще не являетесь нашим клиентом — не проблема! Вы можете пройти наше обучение за символическую плату: всего 4500 рублей.
 
Что включает в себя бесплатное обучение трейдингу:
Видеокурс
Доступ к профессиональным макроэкономическим и корпоративным новостям NYSE
Доступ к закрытым вебинарам 
Доступ к записям новых лекций
Каждый месяц количество уроков увеличивается! Если вы приобретаете доступ к обучающему порталу или являетесь нашим клиентом, то вы получаете абсолютно все новые видеоролики и возможность участвовать в наших закрытых вебинарах.
Какой же новостной трейдинг без хорошей новостной ленты? Мы заботимся и помогаем тем, кто работает с нами, поэтому в личном кабинете помимо доступа к обучающим видео и вебинарам вы сможете прочитать все самые свежие и актуальные макроэкономические и корпоративные новости NYSE в реальном времени абсолютно бесплатно. Мы зарабатываем, когда зарабатываете вы!
 Полная информация о бесплатном обучающем курсе